An experimental weight-loss medication was shown to help people lose nearly 25% of their body weight in early-stage 1a/2b trials. The drug, amycretin — developed by Novo Nordisk — works by replicating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback